All In MedTech

Device Trial Radar · NCT07834658

Effects of Transcutaneous Tibial and Auricular Vagus Nerve Stimulation in Females With Primary Dysmenorrhea

Effects of Transcutaneous Tibial and Auricular Vagus Nerve Stimulation on Pain and Autonomic Function in Females With Primary Dysmenorrhea

Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

66

Planned (sponsor's estimate)

Start

Nov 10, 2026

Primary completion

Jun 30, 2027

Study completion Jul 31, 2027

Sponsor

Lead sponsor
Riphah International UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 22, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 14 years, up to 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary dysmenorrhea is a common gynecological condition characterized by painful menstrual cramps that can negatively affect daily activities and quality of life. Non-invasive neuromodulation techniques, including Transcutaneous Tibial Nerve Stimulation (TTNS) and Transcutaneous Auricular Vagus Nerve Stimulation (taVNS), have shown potential for pain management and modulation of autonomic nervous system function. However, limited evidence exists regarding the comparative and combined effects of these interventions. This randomized controlled trial aims to evaluate the comparative and combined effects of TTNS and taVNS on pain, autonomic function, menstrual symptoms, and NSAID consumption in females with primary dysmenorrhea. Eligible participants will be randomly assigned to one of four groups: TTNS, taVNS, combined TTNS + taVNS, or sham stimulation. Outcome measures will be assessed before and after the intervention period by a blinded assessor.

Conditions

  • Primary Dysmenorrhea (PD)

Interventions

  • Transcutaneous Tibial Nerve Stimulation (TTNS)Device

    Electrical stimulation will be delivered through a TENS device using surface electrodes placed over the posterior tibial nerve for 30 mins according to the study protocol for the management of primary dysmenorrhea. The intervention will be applied for 5 consecutive days, including 2 days before and 3 days during the mensturation period.

  • Transcutaneous Auricular Vagus Nerve Stimulation (TaVNS)Device

    Electrical stimulation delivered through a TENS device using surface electrodes placed on the auricular branch of the vagus nerve for 30 mins according to the study protocol for the management of primary dysmenorrhea. The intervention will be applied for 5 consecutive days, including 2 days before and 3 days during the mensturation period.

  • TTNS+TaVNSDevice

    Electrical stimulation delivered through a TENS device to both the posterior tibial nerve and the auricular branch of the vagus nerve sequentially according to the study protocol. The intervention will be applied for 5 consecutive days, including 2 days before and 3 days during the mensturation period.

  • Sham StimulationDevice

    Sham stimulation delivered using the same TENS device and electrode placement as the active intervention but without therapeutic electrical stimulation. The intervention will be applied for 5 consecutive days, including 2 days before and 3 days during the mensturation period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Dysmenorrhea Severity - WaLIDD ScoreTime frame: Baseline, 4th Week, 8th Week , and 12th Week
  2. Pain Intensity - Numeric Pain Rating Scale (NPRS)Time frame: Baseline, 4th Week, 8th Week , and 12th Week
  3. Autonomic Function - Heart Rate Variability (RMSSD)Time frame: Baseline, 4th Week, 8th Week , and 12th Week

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Postgraduate Lab of Riphah International University

    Islamabad, Fedral Teritory, Pakistan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.